-+ 0.00%
-+ 0.00%
-+ 0.00%

Vector Science signs amended 10-year cGMP manufacturing deal with LyoGenesis

PUBT·08/17/2026 11:45:15
Listen to the news
Vector Science signs amended 10-year cGMP manufacturing deal with LyoGenesis
  • Vector signed an amended, 10-year manufacturing and testing agreement with LyoGenesis, effective Aug. 13, 2026.
  • Deal secures exclusive, U.S.-based cGMP capacity for Vector’s lyophilized peptide pharmaceutical products at LyoGenesis’ Mequon, Wisconsin facility.
  • Verlytix will handle quality assurance inspections before batch release; product title transfers to Vector on delivery.
  • Contract renews automatically in one-year terms after the initial decade; financial terms were not disclosed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vector Science and Therapeutics Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608170745PR_NEWS_USPR_____LA27298) on August 17, 2026, and is solely responsible for the information contained therein.